Expression of MDM2 mRNA, MDM2, P53 and P16 Proteins in Urothelial Lesions in the View of the WHO 4<sup>th</sup> Edition Guidelines as a Molecular Insight towards Personalized Medicine.

Open Access Maced J Med Sci · 2017 · PMC5591584 · PMID 28932295

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

highly significantno p-value reported

Conversely, T2 tumours showed highly significant P53 > 40% expression in 55%, in contrast to only 14.4%.

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.